“…Preeclampsia can be subdivided into early-onset (<34 weeks of gestation) and late-onset (>34 weeks of gestation) variants [82,83,84], of which the latter is the most frequent [85,86,87]. The pathophysiology observed between early-and late-onset preeclampsia is different: in late-onset preeclampsia, the angiogenic/anti-angiogenic imbalance is milder than in the early-onset variant [62,65,70,88,89,90,91,92,93,94]. Indeed, such factors [placental growth factor (PlGF), soluble vascular endothelial growth factor receptor-1 (or soluble fms-like tyrosine kinase-1, sFLT1), soluble endoglin] and their ratios are considered biomarkers for the detection of early-onset preeclampsia [62,63,71,86,88,89,95,96,97,98,99].…”